National Cancer Institute
NCI Announces Major Enhancements to CancerNet Web Site
17 Nov 99 | The National Cancer Institute (NCI) today announced major enhancements to its CancerNet™ Web site, a free gateway to reliable information about cancer for patients, health professionals, and people at risk for cancer.
The first-time user will ...
Scientists Report First Responses in Cancer Patients to A Recombinant Immunotoxin
08 Nov 99 | However, despite the great promise of this approach, there have been no published reports of cancer patients responding to a recombinant immunotoxin. For the three other patients, Kreitman and colleagues observed partial responses, detecting a 98 ...
Weighing the Risks and Benefits of Tamoxifen to Reduce Risk of Breast Cancer
02 Nov 99 | Following release of the BCPT results, NCI produced and distributed the Breast Cancer Risk Assessment Tool, software to help physicians estimate a woman's risk of developing the disease.
The article published today provides physicians and ...
Misconceptions Persist Among Older Women In Spite Of Rising Mammography Rates
20 Oct 99 | NCI and HCFA conducted the survey of breast cancer and mammography screening knowledge, attitudes, and behaviors to help evaluate ongoing mammography education efforts and to identify areas needing additional attention.
Use of the Medicare ...
Federal Institutes and The Robert Wood Johnson Foundation Create Tobacco Use Research Centers
18 Oct 99 | Seven academic institutions have been awarded grants totaling $14.5 million by the National Cancer Institute (NCI) and the National Institute on Drug Abuse (NIDA) to create the Transdisciplinary Tobacco Use Research Centers for studying tobacco ...
NCI Awards First Contracts for Unconventional Innovations Program
08 Oct 99 | The National Cancer Institute (NCI) announced today that it has awarded the first five contracts of an innovative new program to develop novel, "one-stop" technologies capable of both detecting and destroying tumor cells.
The UIP builds on ...
NCI Announces SPORE Grants for Ovarian Cancer Research
07 Oct 99 | The National Cancer Institute (NCI) has announced grants to four institutions for research on ovarian cancer.
The Fox Chase Cancer Center in Philadelphia received funds to develop an interdisciplinary ovarian cancer program focused on ...
NCI Begins Funding Early Detection Research Network: 18 Biomarker Developmental Laboratories Seek Tests for Common Cancers
06 Oct 99 | These awards create 18 Biomarker Developmental Laboratories to identify, characterize, and refine techniques for finding molecular, genetic, and biologic early warning signals of cancer.
The laboratories are part of the Early Detection Research ...
Monitoring NCI-Sponsored Clinical Trials
04 Oct 99 | In addition to these basic protections, mandated by federal regulations, the National Cancer Institute (NCI) has established a program for continuous monitoring of all trials that it conducts or sponsors.
For more information: NCI Guidelines: ...
United States and Ireland Establish Historic Cancer Collaboration
03 Oct 99 | Top scientists from the National Cancer Institute (NCI) and the National Institutes of Health (NIH) today entered into an historic tripartite agreement to enhance cancer research and treatment in Ireland.
The Ireland-Northern Ireland-NCI Cancer ...
Lymphoma Vaccine Enters Large-Scale Clinical Trials
27 Sep 99 | Complete molecular remissions were documented, using the high technology tool of polymerase chain reaction (PCR), in 75 percent of patients after vaccination. To create the vaccine, researchers fused tumor cells taken from individual patients to ...
NCI Assists Establishment of DNA Microarray Facilities
21 Sep 99 | The National Cancer Institute (NCI) announced today that it will spend $4.1 million to help 24 cancer research centers throughout the country purchase equipment needed to launch DNA microarray facilities.
Klausner said the microarray centers also...
NCI's Role in the Development of Endostatin
15 Sep 99 | In February 1999, the NCI reported that two of its scientists had conducted experiments with mouse endostatin in Folkman's laboratory.
With the availability of human endostatin produced by EntreMed, Inc., Rockville, Md., using a separate and ...
New Study Will Assess Colorectal Cancer Screening Practices
08 Sep 99 | Investigators from NCI, the Centers for Disease Control and Prevention, and the Health Care Financing Administration are collaborating to gather for the first time national data on colorectal screening practices.
It will assess physicians' ...
Monograph Highlights Research in Native American Populations
26 Aug 99 | The report, called Native Outreach: A Report to American Indian, Alaska Native, and Native Hawaiian Communities, highlights the results of seven research studies conducted in Native American communities.
These studies include the Prevention of ...
NCI's Tumor Gene Index Reaches Its Two-Year Mark
10 Aug 99 | Two years ago this month, the National Cancer Institute (NCI) and Vice President Al Gore publicly launched a historic initiative to compile on the Internet the first comprehensive record, or index, of genes involved in human cancer.
Today, the ...
NCI's Division of Clinical Sciences Will Test Thalidomide in Patients with Advanced Colon Cancer
06 Aug 99 | The Division of Clinical Sciences at the National Cancer Institute (NCI) is studying the effectiveness of the drug thalidomide in preventing the recurrence of colorectal cancer in patients with advanced disease that has been successfully treated ...
NCI Leases New Supercomputer
02 Aug 99 | The National Cancer Institute (NCI) today announced the signing of a three-year, $6.5 million agreement with Silicon Graphics, Inc., (SGI) to lease a Cray SV1 supercomputer.
Maizel said the new SGI supercomputer, which should be fully operational...
HMO Research Network Receives NCI Funding to Establish Cancer Research Network
20 Jul 99 | Ten major, non-profit managed care organizations that are members of the HMO Research Network will participate in the project, known as the Cancer Research Network.
Participating HMO research organizations include the Center for Health Studies (...
Dinah Singer Named New Director of NCI's Division of Cancer Biology
19 Jul 99 | The National Cancer Institute (NCI) today named Dinah S. Singer, Ph.D., a well-recognized researcher in studies of transcriptional control in the immune system, as director of its Division of Cancer Biology.
The Division of Cancer Biology (DCB) ...